DNAJC2 and cancer: We speculate that during cancer, which also correlates to high levels of G4s76, ZRF1 is likely recruited to chromatin where it acts to prevent the entry into senescence, making ZRF1 a new player during senescence activation and modulation of cancer aggressiveness.